Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
about
Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis casesIs IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?The spectrum of latent tuberculosis: rethinking the biology and intervention strategiesResponse to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-respondersIP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapyKinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study.Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populationsEffect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis.T cell monitoring of chemotherapy in experimental rat tuberculosis.Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages.Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting.Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay resultsInterferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the EvidenceCurrent issues on molecular and immunological diagnosis of tuberculosis.Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis.The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature.Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.The challenging task of screening and monitoring tuberculosis infection in candidates for biological therapies.Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy
P2860
Q28475371-AE7ED148-39A7-4974-A499-C70144BB7AE1Q28749413-1B003A42-2AB9-4C96-A806-81AC06DCEB1BQ29619404-F5ED4DB7-C7D7-4160-A087-2AF379FA902AQ30840526-B905120D-5F74-4475-9A27-9E98AF7EDC88Q30907264-30DF45F5-3781-41E8-8B43-9BC95B0F3CAAQ33377055-0EF93E8E-BE71-4F3F-BB19-C9CE4ACE0811Q33567995-DAB0126A-2034-4743-9004-A57CC53D57CEQ33867531-7BC3C0C6-B45E-465B-A658-4CF037DC7C1DQ33905874-4AE7580A-83AF-4AFD-8724-13D79F88DC0BQ33909191-25FA0982-1B0B-4052-B259-A94077A38C68Q34069608-112286C0-49BB-4152-BEF0-74FFA0FD3785Q34432005-07C81817-BBDE-4826-B9EE-1CEC72C10F94Q35054208-A61E301E-6CB3-498C-A18E-DF3F0DEBE227Q35139430-E450BFF6-1FFA-405A-A76C-9B4B63B2F72EQ35818084-063DB927-DE2F-4813-B5EC-04689F05380CQ36283130-4A2AB9BB-B592-47F6-841F-664BF1E67ED1Q36516077-113C421C-7B7C-4B8D-B7CD-AC3AFC023561Q36606393-8AF7E6B8-1A6B-467B-9A09-B577B874707DQ36637982-80EBDA45-EEC4-43A7-A32F-C0BFF9EAA02CQ36861562-B33DAB3D-8E46-4D4A-BEAE-E71CB7D4B799Q37724458-9B4052D5-FF79-4F1C-88C5-89D3B92D5452Q38211731-7F42CE75-44B2-404F-8CD4-015D3808ED51Q39381637-7468C3A1-60A2-4DC2-ACD1-F8A546DEA37EQ40072142-05AC18C2-032B-46FB-B917-0861EEA0CB70Q41699854-B48BAA32-ED6A-42C8-B18A-BD9AC4A3AFC1Q45401329-6B8C1FC4-611E-4D65-8CAC-6ABB760AF820Q46654948-48C906EA-B33E-4CC5-BB05-534CF13B5254Q58924838-925AAF7B-3A70-47C4-BEC8-45C2BF545238
P2860
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Isoniazid prophylaxis differen ...... um tuberculosis: a pilot study
@ast
Isoniazid prophylaxis differen ...... um tuberculosis: a pilot study
@en
type
label
Isoniazid prophylaxis differen ...... um tuberculosis: a pilot study
@ast
Isoniazid prophylaxis differen ...... um tuberculosis: a pilot study
@en
prefLabel
Isoniazid prophylaxis differen ...... um tuberculosis: a pilot study
@ast
Isoniazid prophylaxis differen ...... um tuberculosis: a pilot study
@en
P2093
P2860
P50
P356
P1433
P1476
Isoniazid prophylaxis differen ...... um tuberculosis: a pilot study
@en
P2093
Duilio Dainotto
Fabrizio Poccia
Federica Bizzoni
Gianfranco Anzidei
M Pasquale Parracino
Ornella Butera
P2860
P2888
P356
10.1186/1465-9921-8-5
P577
2007-01-27T00:00:00Z
P5875
P6179
1049800836